Study of clinical profile and laboratory markers in early diagnosis of severe dengue in children

Suprith Amblihalli Srinivas; Ramesh Pol

doi:10.18203/2349-3291.ijcp20243857

Authors

Suprith Amblihalli Srinivas Department of Pediatrics, S. Nijalingappa Medical College, Bagalkot, Karnataka, India
Ramesh Pol Department of Pediatrics, S. Nijalingappa Medical College, Bagalkot, Karnataka, India https://orcid.org/0000-0001-7440-5113

DOI:

https://doi.org/10.18203/2349-3291.ijcp20243857

Keywords:

Clinical, Laboratory markers, Severe dengue

Abstract

Background: Dengue fever is a mosquito-borne viral disease that presents as asymptomatic or can clinically manifest with symptoms like hemorrhagic fever and shock. Alteration of various other hematological parameters includes leukopenia, thrombocytopenia, hematocrit changes, and liver enzyme alteration. this study aimed to investigate dengue patients' clinical profiles, laboratory parameters, and outcomes across different severity levels.

Methods: This is a prospective hospital-based study of 125 patients conducted at S. Nijalingappa medical college, Bagalkot over 18 months from August 2022 to February 2024. the study included 125 cases with serologically confirmed (NS1ag and/ IgM) between 1 to 14 years and categorized according to WHO classification.

Results: Out of 125 patients, 62 and 33 had dengue with and without warning signs, and 30 had severe dengue, 52% of cases had leucopenia, and thrombocytopenia was present in 105 (84%) cases with significantly higher in severity groups. Elevated SGOT 108 (86.4%) and SGPT 72 (57.6%) were commonly seen in disease severity groups. Liver dysfunction was observed in 86.4% of patients. All patients survived and improved with appropriate treatment.

Conclusions: This study highlights the importance of clinical and hematological parameters in the early recognition and management of severe dengue cases. Liver dysfunction was common in severe cases. Despite the varying severity, all patients in this cohort had favorable outcomes, emphasizing the effectiveness of proper management strategies.

Metrics

Metrics Loading ...

References

World Health Organization. Dengue and severe dengue. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed on 25 July 2024.

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7.

WHO. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization. 1997. Available at: https://apps.who.int/iris/bitstream/handle/10665/41988/9241545003_eng.pdf;sequence=1. Accessed on 20 October 2024.

Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue Fever in children. Iran J Pediatr. 2012;22(2):231-6.

Pongpan S, Wisitwong A, Tawichasri C, Patumanond J, Namwongprom S. Development of dengue infection severity score. ISRN Pediatr. 2013;2013:845876.

Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. N Am J Med Sci. 2013;5(8):480-5.

Chhina RS, Goyal O, Chhina DK, Goyal P, Kumar R, Puri S. Liver function tests in patients with dengue viral infection. Dengue Bull. 2008;32:110-7.

Siddappa FD. Prevalence of hepatic dysfunction in children with dengue fever. Int J Pediatr Res. 2019;6(01):8-16.

Selvan T, Saravanan P, Nagaraj MV, Tudu MN. Study of hepatic dysfunction of dengue fever in children. Int J Contemp Pediatr. 2017;4(3):901-4.

Tambolkar S A, Mishra A, Joshi H, Agarkhedkar S. Liver Functions as a marker of severity of disease in children with Dengue fever. Webmed Central Paediatr. 2015;6(8):WMC004962.